Emran Ali | Biotechnology | Best Researcher Award

Published on | Editorial Board by World Top Scientists

Research Excellence Award

Emran Ali
Affiliation Alcorn State University
Country United States
Scopus ID 57200798179
Google Scholar Research Profile
Documents 2
Citations 36
h-index 2
Subject Area Biotechnology
Event World Top Scientist Awards

Emran Ali is affiliated with Alcorn State University, United States, and has contributed to biotechnology through scholarly publications, scientific collaboration, and applied research. His work emphasizes molecular diagnostics, plant pathology, disease management, and biotechnology-driven agricultural innovation. Academic metrics available through recognized research indexing services indicate measurable research visibility and scholarly influence within specialized scientific domains. These contributions collectively demonstrate sustained participation in international research activities and provide a foundation for professional recognition within the global scientific community.[1]

Abstract

Emran Ali has established an academic profile through research activities focused on biotechnology, molecular diagnostics, plant pathology, and disease management. His publications demonstrate scientific engagement in developing innovative diagnostic approaches, understanding plant–pathogen interactions, and improving agricultural sustainability through biotechnology. Indexed publications, citation records, and collaborative research indicate continued participation in internationally recognized scientific investigations. These measurable scholarly outputs contribute to scientific communication while supporting advancements in agricultural biotechnology and molecular plant sciences. The available academic indicators collectively provide evidence of research productivity, visibility, and professional contribution within the broader scientific research community.[1]

Keywords

Biotechnology, Molecular Diagnostics, Plant Pathology, Agricultural Biotechnology, Disease Detection, Plant Health, Molecular Biology, Scientific Research, Crop Protection, Academic Excellence.

Introduction

Biotechnology continues to transform modern agriculture through advanced molecular techniques that improve disease diagnosis, crop protection, and sustainable production systems. Researchers working in these areas contribute to scientific understanding by integrating laboratory discoveries with practical agricultural applications. Emran Ali’s published studies reflect this interdisciplinary approach, supporting innovation in plant health management while strengthening scientific knowledge related to pathogen detection, disease resistance, and molecular analytical methods used in contemporary agricultural biotechnology.[2]

Research Profile

The research profile of Emran Ali demonstrates participation in internationally indexed scientific publications within biotechnology and molecular plant pathology. Bibliometric indicators, including indexed documents, citation performance, and research visibility, illustrate continued academic engagement. Collaboration with researchers across multiple institutions has contributed to studies involving molecular detection technologies, fungal diseases, pathogen characterization, and crop improvement. These activities collectively strengthen his scholarly profile while supporting the advancement of evidence-based agricultural biotechnology research.[1][3]

Research Contributions

Research contributions include investigations into molecular diagnostic technologies, pathogen identification, disease resistance mechanisms, and biotechnology-based crop protection strategies. Published studies have supported improved laboratory detection methods while expanding scientific understanding of economically important plant diseases. Through collaborative research, these contributions assist agricultural scientists in developing practical disease management approaches that promote sustainable crop production and strengthen the application of biotechnology within plant health systems.[2][4]

Publications

The scholarly publications associated with Emran Ali primarily focus on biotechnology, molecular diagnostics, plant pathology, fungal diseases, crop protection, and pathogen detection. His research includes collaborative studies published in internationally recognized peer-reviewed journals, reflecting scientific contributions to agricultural biotechnology and molecular plant sciences. These publications demonstrate continued engagement with emerging research challenges while supporting innovation through interdisciplinary scientific collaboration and evidence-based methodologies.[2][3]

Research Impact

Research impact is reflected through citation activity, indexed publications, collaborative investigations, and measurable academic visibility. Scientific findings have contributed to molecular diagnostic development, improved understanding of plant diseases, and practical agricultural biotechnology applications. Citation metrics and international indexing provide evidence that published work has been referenced within subsequent scientific literature, supporting continued dissemination of knowledge and contributing to ongoing developments in biotechnology research.[1][3]

Award Suitability

Recognition through the World Top Scientist Awards aligns with established academic criteria that value research productivity, scholarly visibility, international collaboration, and measurable scientific contribution. The available research indicators, publication record, and biotechnology-focused investigations demonstrate sustained participation in scientific advancement. These characteristics illustrate professional commitment to research excellence while supporting continued innovation within biotechnology and molecular plant pathology through internationally recognized academic activities.[1][4]

Conclusion

Emran Ali has developed a research profile centered on biotechnology, molecular diagnostics, plant pathology, and agricultural innovation. Indexed publications, collaborative scientific studies, and measurable bibliometric indicators demonstrate continuing engagement with internationally recognized research activities. Collectively, these achievements reflect meaningful scholarly participation while contributing to scientific knowledge that supports sustainable agriculture, improved disease management, and ongoing advancements within biotechnology research.[1]

External Links

References

  1. Ali, M. E., & Amiri, A. (2018). Selection pressure pathways and mechanisms of resistance to the demethylation inhibitor difenoconazole in Penicillium expansum. Frontiers in Microbiology, 9, 2472.
    https://doi.org/10.3389/fmicb.2018.02472
  2. Waliullah, S., Ling, K. S., Cieniewicz, E. J., Oliver, J. E., Ji, P., & Ali, M. E. (2020). Development of loop-mediated isothermal amplification assay for rapid detection of cucurbit leaf crumple virus. International Journal of Molecular Sciences, 21(5), 1756.
    https://doi.org/10.3390/ijms21051756
  3. Hudson, O., Fulton, J. C., Dong, A. K., Dufault, N. S., & Ali, M. E. (2021). Fusarium oxysporum f. sp. niveum molecular diagnostics: Past, present and future. International Journal of Molecular Sciences, 22(18), 9735.
    https://doi.org/10.3390/ijms22189735
  4. Stackhouse, T., Martinez-Espinoza, A. D., & Ali, M. E. (2020). Turfgrass disease diagnosis: Past, present, and future. Plants, 9(11), 1544. https://doi.org/10.3390/plants9111544
  5. Ali, M. E., Gunn, M., Stackhouse, T., Waliullah, S., Guo, B., Culbreath, A., & Brenneman, T. (2021). Sensitivity of Aspergillus flavus isolates from peanut seeds in Georgia to azoxystrobin, a quinone outside inhibitor (QoI) fungicide. Journal of Fungi, 7(4), 284.
    https://doi.org/10.3390/jof7040284

Irving Lara | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Published on | Editorial Board by World Top Scientists

Dr. Irving Lara | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Research assistant at Centro de Investigación Biomédica de Occidente, Mexico

Dr. Irving Jair Lara Navarro is a Mexican researcher specializing in genetics and molecular biology. Born on December 9, 1990, in Guadalajara, Jalisco, he has dedicated his career to advancing genetic research, particularly in gene therapy. His work integrates molecular diagnostics, biotechnology, and clinical applications, making significant contributions to biomedical sciences. With a passion for teaching and research, he has been actively involved in academia and laboratory settings, working to bridge the gap between fundamental genetics and medical applications. Dr. Lara Navarro has played a key role in developing innovative approaches for genetic modification, particularly using CRISPR/Cas9 technology. His expertise extends to epidemiological surveillance, laboratory diagnostics, and academic instruction. Throughout his career, he has collaborated with various research institutions, healthcare professionals, and academic institutions, fostering a multidisciplinary approach to genetics. His commitment to scientific excellence and education continues to drive his contributions to the field.

Professional Profile

Education

Dr. Irving Jair Lara Navarro pursued his academic journey in biological sciences, earning a Bachelor’s degree in Biology from the University of Guadalajara (CUCBA) in 2014. His undergraduate research focused on optimizing transduction conditions in keratinocytes using lentiviral vectors. Continuing his passion for genetics, he pursued a Doctorate in Human Genetics at the University of Guadalajara (CUCS), completing it in 2024. His doctoral research revolved around gene therapy using CRISPR/Cas9 technology for modifying the F9 gene in human mesenchymal cells, aiming to enhance the production of Factor IX, a crucial protein for blood clotting. This work has potential therapeutic applications, particularly in treating hemophilia. His academic training has provided him with expertise in molecular biology, genetic engineering, and biomedical research. His strong foundation in experimental design and genetic modifications has positioned him as a key researcher in the field of gene therapy and molecular medicine.

Professional Experience

Dr. Lara Navarro has gained extensive professional experience in research and academia. From 2020 to 2021, he worked as a Research Technician at the Mexican Institute of Social Security (IMSS), contributing to nucleic acid extraction and molecular diagnostics in epidemiological surveillance. He later joined Laboratorio Biodiagnóstica in 2021, where he worked as a Molecular Biology Laboratory Technician, managing laboratory operations, coordinating research teams, and implementing molecular analysis techniques. In addition to his laboratory roles, he has been actively involved in teaching. He served as an Adjunct Professor at Tecmilenio University (Zapopan) from 2021 to 2022, teaching basic sciences at the high school level. Since 2023, he has been a faculty member at Universidad Guadalajara Lamar, where he teaches genetics and biomolecular sciences to medical students. His combined experience in laboratory research and academia has strengthened his ability to contribute to both scientific discovery and education.

Research Interests

Dr. Lara Navarro’s primary research interests lie in genetic engineering, molecular biology, and gene therapy. His doctoral research on CRISPR/Cas9-based gene modification for Factor IX production highlights his focus on therapeutic applications of molecular genetics. He is particularly interested in genetic therapies for hematological disorders, biotechnology applications in medicine, and the development of precision medicine approaches. His expertise in nucleic acid manipulation and viral vector systems contributes to advancements in personalized genetic treatments. Additionally, he has a keen interest in molecular diagnostics and epidemiological surveillance, particularly in developing genetic testing methodologies for disease prevention and treatment. As a researcher, he aims to explore the potential of stem cell therapy, regenerative medicine, and CRISPR-based genome editing for clinical applications. His work aims to bridge the gap between fundamental genetic research and practical medical solutions, contributing to cutting-edge advancements in biomedical sciences.

Awards and Honors

While Dr. Lara Navarro has demonstrated exceptional expertise in genetics and molecular biology, his professional journey is still evolving in terms of formal recognitions. His research in CRISPR/Cas9 gene therapy holds significant potential for future awards and funding opportunities. As an emerging scientist, he has been recognized for his contributions to molecular diagnostics and epidemiological research at IMSS, where he played a crucial role in laboratory procedures during the COVID-19 pandemic. His involvement in academia and research has earned him respect within the scientific and medical communities. While he may not yet have received high-profile research awards, his work on genetic modifications and biomedical applications positions him as a strong candidate for future honors in genetics, biotechnology, and medical research. With continued research output and publications, he is likely to receive formal recognition for his contributions to the field of genetic engineering and molecular medicine.

Conclusion

Dr. Irving Jair Lara Navarro has a strong foundation in genetics, molecular biology, and research methodologies, making him a promising candidate. However, to be a strong contender for the Best Researcher Award, he should focus on publishing in high-impact journals, securing research funding, and increasing international recognition. If these aspects are addressed, he would be a more competitive candidate for the award.

Publications Top Noted

  • CRISPR/Cas9 Edition of the F9 Gene in Human Mesenchymal Stem Cells for Hemophilia B Therapy
    • Authors: Lara-Navarro, I.J., Jave-Suárez, L.F., Marchal, J.A., Jaloma-Cruz, A.R.
    • Year: 2024
    • Journal: Life
    • Citations: 0
  • Current Therapies in Hemophilia: From Plasma-Derived Factor Modalities to CRISPR/Cas Alternatives
    • Authors: Lara-Navarro, I.J., Jaloma-Cruz, A.R.
    • Year: 2022
    • Journal: Tohoku Journal of Experimental Medicine
    • Citations: 3
  • Genetic analysis for carrier diagnosis in hemophilia A and B in the Mexican population: 25 years of experience
    • Authors: González-Ramos, I.-A., Mantilla-Capacho, J.-M., Luna-Záizar, H., Evangelista-Castro, N., Jaloma-Cruz, A.R.
    • Year: 2020
    • Journal: American Journal of Medical Genetics, Part C: Seminars in Medical Genetics
    • Citations: 5
  • Molecular thrombophilic profile in Mexican patients with idiopathic recurrent pregnancy loss
    • Authors: López-Jiménez, J.J., Porras-Dorantes, Á., Juárez-Vázquez, C.I., Lara-Navarro, I.J., Jaloma-Cruz, A.R.
    • Year: 2016
    • Journal: Genetics and Molecular Research
    • Citations: 19
  • Two girls with a de novo Xq rearrangement of paternal origin: T(X;9)(q24;q12) or rea(X)dup q
    • Authors: Vásquez-Velásquez, A.I., Rivera, H., Castro, A.G., Mendoza-Pérez, P., García-Ortiz, J.E.
    • Year: 2016
    • Journal: Taiwanese Journal of Obstetrics and Gynecology
    • Citations: 0
  • A further inv dup/del 9p de novo rearrangement. Reappraisal of 25 instances
    • Authors: Lara-Navarro, I.J., Córdova-Fletes, C., García-Ruiz, A., Rivera, H.
    • Year: 2015
    • Journal: Gene Reports
    • Citations: 0